InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,904.40
(
0.29%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.43
(
-1.25%
)
Bitcoin
56,239.34
(
0.70%
)
Post# of 463757
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

McMagyar

Send PM Follow Ignore
Followers 44
Posts 10460
Boards Moderated 0
Alias Born 01/13/2016

McMagyar

Re: McMagyar post# 73407

Sunday, 08/14/2016 4:54:34 PM

Sunday, August 14, 2016 4:54:34 PM

Post# of 463757
Efficacy argument for immediate availability of A2-73 for Mild to Moderate AD Patients:

Patients who have found the side effects of ARICEPT/Donexpipil Unacceptable should immediately be allowed (with some exceptions) to take A2-73..

Patients who are not experiencing any benefit to A2-73 should be allowed to
take A2-73 as MonoTherapy or in conjunction with DZP..

Patients with INSOMNIA and ALZHEIMERS should IMMEDIATELY be allowed to take A2-73!

Patients with INSOMNIA and DEMENTIA of ANY KIND should immediately be allowed to take A2-73..

Let's start HELPING PEOPLE..What the heck are we waiting for?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!